Drug Shortage Report for DANTRIUM CAPSULES
Report ID | 215589 |
Drug Identification Number | 01997602 |
Brand name | DANTRIUM CAPSULES |
Common or Proper name | DANTROLENE SODIUM |
Company Name | ENDO OPERATIONS LTD. |
Market Status | MARKETED |
Active Ingredient(s) | DANTROLENE SODIUM |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 Capsules |
ATC code | M03CA |
ATC description | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2023-12-15 |
Actual start date | |
Estimated end date | 2024-01-31 |
Actual end date | 2024-02-01 |
Shortage status | Resolved |
Updated date | 2024-02-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-02-07 | French | Compare |
v3 | 2024-02-07 | English | Compare |
v2 | 2024-01-11 | French | Compare |
v1 | 2024-01-11 | English | Compare |
Showing 1 to 4 of 4